Literature DB >> 20864688

VHL inactivation induces HEF1 and Aurora kinase A.

Jianyong Xu1, Huapeng Li, Bo Wang, Yan Xu, Jiayin Yang, Xiaofei Zhang, Sarah K Harten, Deepa Shukla, Patrick H Maxwell, Duanqing Pei, Miguel A Esteban.   

Abstract

The ciliary hypothesis for cystic renal diseases postulates that most of these conditions result from abnormalities in the primary cilium, a microtubule-based structure that acts as a sensor for extracellular cues. Inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene predisposes to renal cysts and clear cell renal cell carcinoma. VHL plays a critical role in the formation of primary cilia in kidney epithelium, but the underlying mechanisms are poorly understood. Here, we demonstrate that VHL inactivation induces HEF1/Cas-L/NEDD9 and Aurora kinase A via the stabilization of hypoxia-inducible factors 1 and 2. Aurora kinase A is a mitotic kinase commonly upregulated in cancer that causes regression of the primary cilium by promoting histone deacetylase-dependent tubulin depolymerization of the ciliary axoneme. HEF1/Cas-L/NEDD9 is a component of focal adhesions that has a prominent role in inducing metastasis and that colocalizes with Aurora kinase A at the centrosome, thereby enhancing the harmful effect of Aurora kinase A on the cilium. Suppression of this pathway improved the formation of primary cilia and reduced cell motility in VHL-defective renal cancer cells. Our results highlight the gatekeeper role of VHL in the kidney epithelium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864688      PMCID: PMC3014016          DOI: 10.1681/ASN.2010040345

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

1.  Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.

Authors:  Sun-Hee Kim; Dianren Xia; Sang-Wook Kim; Vijaykumar Holla; David G Menter; Raymond N Dubois
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

2.  Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

Authors:  Raju R Raval; Kah Weng Lau; Maxine G B Tran; Heidi M Sowter; Stefano J Mandriota; Ji-Liang Li; Christopher W Pugh; Patrick H Maxwell; Adrian L Harris; Peter J Ratcliffe
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Antigens recognized by autologous antibody in patients with renal-cell carcinoma.

Authors:  M J Scanlan; J D Gordan; B Williamson; E Stockert; N H Bander; V Jongeneel; A O Gure; D Jäger; E Jäger; A Knuth; Y T Chen; L J Old
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

4.  Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).

Authors:  M Sattler; R Salgia; G Shrikhande; S Verma; N Uemura; S F Law; E A Golemis; J D Griffin
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain.

Authors:  Martijn P Lolkema; Michelle L Gervais; Cristel M Snijckers; Richard P Hill; Rachel H Giles; Emile E Voest; Michael Ohh
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

Review 6.  Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid.

Authors:  William Kevin Kelly; Paul A Marks
Journal:  Nat Clin Pract Oncol       Date:  2005-03

7.  Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.

Authors:  Miguel A Esteban; Maxine G B Tran; Sarah K Harten; Peter Hill; Maria C Castellanos; Ashish Chandra; Raju Raval; Tim S O'brien; Patrick H Maxwell
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

Review 8.  Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease.

Authors:  Gregory J Pazour
Journal:  J Am Soc Nephrol       Date:  2004-10       Impact factor: 10.121

9.  The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.

Authors:  M Ohh; R L Yauch; K M Lonergan; J M Whaley; A O Stemmer-Rachamimov; D N Louis; B J Gavin; N Kley; W G Kaelin; O Iliopoulos
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

10.  Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.

Authors:  Keiichi Kondo; William Y Kim; Mirna Lechpammer; William G Kaelin
Journal:  PLoS Biol       Date:  2003-12-22       Impact factor: 8.029

View more
  32 in total

1.  Generation of induced pluripotent stem cells from urine.

Authors:  Ting Zhou; Christina Benda; Sarah Duzinger; Yinghua Huang; Xingyan Li; Yanhua Li; Xiangpeng Guo; Guokun Cao; Shen Chen; Lili Hao; Yau-Chi Chan; Kwong-Man Ng; Jenny Cy Ho; Matthias Wieser; Jiayan Wu; Heinz Redl; Hung-Fat Tse; Johannes Grillari; Regina Grillari-Voglauer; Duanqing Pei; Miguel A Esteban
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

Review 2.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

Review 3.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

4.  Control of ciliation in embryogenesis.

Authors:  Anna S Nikonova; Erica A Golemis
Journal:  Nat Cell Biol       Date:  2015-02       Impact factor: 28.824

Review 5.  The extracellular matrix and ciliary signaling.

Authors:  Tamina Seeger-Nukpezah; Erica A Golemis
Journal:  Curr Opin Cell Biol       Date:  2012-07-19       Impact factor: 8.382

6.  Cilia and cilia-associated proteins in cancer.

Authors:  Tamina Seeger-Nukpezah; Joy L Little; Victoria Serzhanova; Erica A Golemis
Journal:  Drug Discov Today Dis Mech       Date:  2013-12-01

7.  Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.

Authors:  Carmelle V Romain; Pritha Paul; Sora Lee; Jingbo Qiao; Dai H Chung
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

8.  The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss.

Authors:  Yan Feng; Ye Wang; Zuoyun Wang; Zhaoyuan Fang; Fei Li; Yijun Gao; Hongyan Liu; Tian Xiao; Fuming Li; Yang Zhou; Qiwei Zhai; Xiaolong Liu; Yihua Sun; Nabeel Bardeesy; Kwok-kin Wong; Haiquan Chen; Zhi-qi Xiong; Hongbin Ji
Journal:  Cancer Res       Date:  2012-10-16       Impact factor: 12.701

9.  β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.

Authors:  Ruhee Dere; Ashley Lyn Perkins; Tasneem Bawa-Khalfe; Darius Jonasch; Cheryl Lyn Walker
Journal:  J Am Soc Nephrol       Date:  2014-10-13       Impact factor: 10.121

10.  HDAC6 inhibition restores ciliary expression and decreases tumor growth.

Authors:  Sergio A Gradilone; Brynn N Radtke; Pamela S Bogert; Bing Q Huang; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Cancer Res       Date:  2013-01-31       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.